27 related articles for article (PubMed ID: 30763134)
1. Annual epidemiological and health insurance disease burden of hip osteoarthritis in Hungary based on nationwide data.
Kajos LF; Molics B; Elmer D; Pónusz-Kovács D; Kovács B; Horváth L; Csákvári T; Bódis J; Boncz I
BMC Musculoskelet Disord; 2024 May; 25(1):406. PubMed ID: 38783258
[TBL] [Abstract][Full Text] [Related]
2. [Experiences with price competition of biosimilar drugs in Hungary].
Hornyák L; Nagy Z; Tálos Z; Endrei D; Ágoston I; Csákvári T; Boncz I
Acta Pharm Hung; 2014; 84(2):83-7. PubMed ID: 25167704
[TBL] [Abstract][Full Text] [Related]
3. The long-term effect of generic price competition on the Hungarian statin market.
Répásy B; Gazsó T; Elmer D; Pónusz-Kovács D; Kajos FL; Csákvári T; Kovács B; Boncz I
BMC Health Serv Res; 2023 May; 23(1):447. PubMed ID: 37147682
[TBL] [Abstract][Full Text] [Related]
4. [Assessment of annual health insurance reimbursement for oncology drugs in Hungary].
Boncz I; Donkáné Verebes E; Oberfrank F; Kásler M
Magy Onkol; 2010 Dec; 54(4):283-8. PubMed ID: 21163758
[TBL] [Abstract][Full Text] [Related]
5. Biosimilar granulocyte colony-stimulating factor uptakes in the EU-5 markets: a descriptive analysis.
Bocquet F; Paubel P; Fusier I; Cordonnier AL; Le Pen C; Sinègre M
Appl Health Econ Health Policy; 2014 Jun; 12(3):315-26. PubMed ID: 24578185
[TBL] [Abstract][Full Text] [Related]
6. [Health insurance reimbursement of dental care in Hungary].
Marada G; Nagy A; Benke B; Boncz I
Fogorv Sz; 2012 Mar; 105(1):3-8. PubMed ID: 22530363
[TBL] [Abstract][Full Text] [Related]
7. Price competition and reimbursement of biosimilar granulocyte-colony stimulating factor in Hungary.
Hornyák L; Nagy Z; Ilku L; Tálos Z; Endrei D; Ágoston I; Csákvári T; Danku N; Répásy B; Boncz I
Expert Rev Pharmacoecon Outcomes Res; 2019 Dec; 19(6):725-731. PubMed ID: 30763134
[No Abstract] [Full Text] [Related]
8. Pharmacoeconomics of granulocyte colony-stimulating factor: a critical review.
Barnes G; Pathak A; Schwartzberg L
Adv Ther; 2014 Jul; 31(7):683-95. PubMed ID: 24989316
[TBL] [Abstract][Full Text] [Related]
9. Update on biosimilars of granulocyte colony-stimulating factor - when no news is good news.
Schulz M; Bonig H
Curr Opin Hematol; 2016 Jan; 23(1):61-6. PubMed ID: 26554886
[TBL] [Abstract][Full Text] [Related]
10. [Physiotherapy from the view of health insurance financing].
Géher P
Orv Hetil; 2013 Dec; 154(48):1917-23. PubMed ID: 24273291
[TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness of granulocyte colony-stimulating factors to prevent febrile neutropenia and related complications in cancer patients in clinical practice: A systematic review.
Mitchell S; Li X; Woods M; Garcia J; Hebard-Massey K; Barron R; Samuel M
J Oncol Pharm Pract; 2016 Oct; 22(5):702-16. PubMed ID: 26769697
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
